“Trisindoline 5 Compound Inhibits Human Breast Cancer Stem Cell Formation by Downregulating the BCL-2 Gene Expression”. International Journal of Cell and Biomedical Science, vol. 1, no. 2, Sept. 2022, pp. 65-69, https://doi.org/10.59278/cbs.v1i2.19.